Literature DB >> 25672371

Measuring decreased serum IgG sialylation: a novel clinical biomarker of lupus.

X-X Chen1, Y-Q Chen2, S Ye2.   

Abstract

INTRODUCTION: The aim of this work was to develop a simple assay to distinguish between patients with rheumatoid arthritis (RA) and patients with systemic lupus erythematosus (SLE) by measuring the serum sialylated IgG (SAIgG).
METHODS: Using a newly established SNA-based ELISA method, we compared the sialylation of immunoglobulin G (IgG) from a healthy control group (n = 41), RA patients (n = 30), SLE patients (n = 45), patients with neuropsychiatric SLE (NPSLE) (n = 30) and patients with juvenile idiopathic arthritis (JIA) (n = 32).
RESULTS: The average SAIgG level in healthy control individuals, RA patients, JIA patients, SLE patients and NPSLE patients was 0.64 ± 0.17, 0.82 ± 0.33, 0.69 ± 0.23, 0.12 ± 0.02 and 0.03 ± 0.01 mg/ml, respectively. The ratio of sialylated IgG to total IgG was significantly decreased in the SLE group (1.88 ± 0.32%) compared with the healthy population (4.64 ± 0.90%).
CONCLUSION: In summary, while the mean serum SAIgG level of RA and JIA patients was similar to that of the healthy population, there was a significant decrease in the serum SAIgG of both SLE groups tested, whereby the level of the NPSLE population group was the lowest.
© The Author(s) 2015.

Entities:  

Keywords:  ELISA assay; Sialylation of immunoglobulin G; autoimmune diseases

Mesh:

Substances:

Year:  2015        PMID: 25672371     DOI: 10.1177/0961203315570686

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  6 in total

Review 1.  Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Ema Prenc; Drazen Pulanic; Maja Pucic-Bakovic; Marija Pezer; Lana Desnica; Radovan Vrhovac; Damir Nemet; Steven Z Pavletic
Journal:  Biochim Biophys Acta       Date:  2016-02-26

Review 2.  Immunoglobulin G N-glycan Biomarkers for Autoimmune Diseases: Current State and a Glycoinformatics Perspective.

Authors:  Konstantinos Flevaris; Cleo Kontoravdi
Journal:  Int J Mol Sci       Date:  2022-05-06       Impact factor: 6.208

3.  Highly Variable Sialylation Status of Donor-Specific Antibodies Does Not Impact Humoral Rejection Outcomes.

Authors:  Thomas Barba; Jean Harb; Stéphanie Ducreux; Alice Koenig; Virginie Mathias; Maud Rabeyrin; Eric Pouliquen; Antoine Sicard; Dimitri Chartoire; Emilie Dugast; Thierry Defrance; Emmanuel Morelon; Sophie Brouard; Valérie Dubois; Olivier Thaunat
Journal:  Front Immunol       Date:  2019-03-20       Impact factor: 7.561

4.  Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.

Authors:  Youxia Liu; Hongfen Li; Huyan Yu; Fanghao Wang; Junya Jia; Tiekun Yan
Journal:  BMC Nephrol       Date:  2022-01-11       Impact factor: 2.388

Review 5.  Induction of Regulatory T Cells by Intravenous Immunoglobulin: A Bridge between Adaptive and Innate Immunity.

Authors:  Gabriel N Kaufman; Amir H Massoud; Marieme Dembele; Madelaine Yona; Ciriaco A Piccirillo; Bruce D Mazer
Journal:  Front Immunol       Date:  2015-09-11       Impact factor: 7.561

6.  Effects of allergic diseases and age on the composition of serum IgG glycome in children.

Authors:  Marija Pezer; Jerko Stambuk; Marija Perica; Genadij Razdorov; Ivana Banic; Frano Vuckovic; Adrijana Miletic Gospic; Ivo Ugrina; Ana Vecenaj; Maja Pucic Bakovic; Sandra Bulat Lokas; Jelena Zivkovic; Davor Plavec; Graham Devereux; Mirjana Turkalj; Gordan Lauc
Journal:  Sci Rep       Date:  2016-09-12       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.